首页> 美国卫生研究院文献>PLoS Clinical Trials >Interferon-Alpha Mediates Restriction of Human Immunodeficiency Virus Type-1 Replication in Primary Human Macrophages at an Early Stage of Replication
【2h】

Interferon-Alpha Mediates Restriction of Human Immunodeficiency Virus Type-1 Replication in Primary Human Macrophages at an Early Stage of Replication

机译:干扰素-α在复制的早期阶段介导人类免疫缺陷病毒1型复制在主要人类巨噬细胞中的限制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Type I interferons (IFNα and β) are induced directly in response to viral infection, resulting in an antiviral state for the cell. In vitro studies have shown that IFNα is a potent inhibitor of viral replication; however, its role in HIV-1 infection is incompletely understood. In this study we describe the ability of IFNα to restrict HIV-1 infection in primary human macrophages in contrast to peripheral blood mononuclear cells and monocyte-derived dendritic cells. Inhibition to HIV-1 replication in cells pretreated with IFNα occurred at an early stage in the virus life cycle. Late viral events such as budding and subsequent rounds of infection were not affected by IFNα treatment. Analysis of early and late HIV-1 reverse transcripts and integrated proviral DNA confirmed an early post entry role for IFNα. First strand cDNA synthesis was slightly reduced but late and integrated products were severely depleted, suggesting that initiation or the nucleic acid intermediates of reverse transcription are targeted. The depletion of integrated provirus is disproportionally greater than that of viral cDNA synthesis suggesting the possibility of a least an additional later target. A role for either cellular protein APOBEC3G or tetherin in this IFNα mediated restriction has been excluded. Vpu, previously shown by others to rescue a viral budding restriction by tetherin, could not overcome this IFNα induced effect. Determining both the viral determinants and cellular proteins involved may lead to novel therapeutic approaches. Our results add to the understanding of HIV-1 restriction by IFNα.
机译:I型干扰素(IFNα和β)直接响应病毒感染而被诱导,导致细胞处于抗病毒状态。体外研究表明,IFNα是病毒复制的有效抑制剂。但是,其在HIV-1感染中的作用尚不完全清楚。在这项研究中,我们描述了与外周血单核细胞和单核细胞衍生的树突状细胞相比,IFNα限制人类原发性巨噬细胞中HIV-1感染的能力。在用IFNα预处理的细胞中,HIV-1复制的抑制作用发生在病毒生命周期的早期。晚期病毒事件(例如出芽和随后的几轮感染)不受IFNα治疗的影响。对早期和晚期HIV-1逆转录本和整合的前病毒DNA的分析证实了IFNα在进入后的早期作用。第一链cDNA的合成略有减少,但后期和整合产物被严重消耗,这表明靶向起始或反转录的核酸中间体。整合前病毒的耗竭比病毒cDNA合成的耗损更大,这提示至少有一个额外的后续靶标的可能性。细胞蛋白APOBEC3G或tetherin在此IFNα介导的限制中的作用已被排除。 Vpu,以前被其他人证明可以挽救tetherin的病毒出芽限制,无法克服这种IFNα诱导的作用。同时确定病毒决定簇和细胞蛋白可能会导致新的治疗方法。我们的结果加深​​了对IFNα限制HIV-1的了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号